White House aims to boost use of COVID drugs, citing plentiful supply
Federal officials say highly effective drugs have been underutilized and could help more Americans fight COVID-19.
Watch CBS News
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies, including the response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
Federal officials say highly effective drugs have been underutilized and could help more Americans fight COVID-19.
The president's chief medical adviser criticized the "disturbing" decision by "a judge with no experience in public health."
InspectIR COVID-19 Breathalyzer test can detect infections using only a breath sample and yield results in less than three minutes.
Citing a "robust response" of antibodies against Omicron in their vaccine trials, the companies said they were planning to submit a request "in the coming days."
As prevalence of the Omicron subvariant nears 90% nationwide, officials around the world are already tracking the rise of dozens of new potential variants.
The agency recently reversed recommendations against routine surveillance of the virus in wildlife, as officials huddle to strategize over the potential threat.
BA.2's prevalence remains highest in the Northeast, where the agency estimates that the variant made up close to three-quarters of new infections.
Immunocompromised Americans are also now eligible for an extra dose, as well as all those first vaccinated with Johnson & Johnson's vaccine.
Rates of breakthrough COVID-19 cases were largely similar among all three vaccines in the CDC's data.
The nation's 18 million children under 5 are the only age group not yet eligible for vaccination.
The Biden administration's new advertising push comes as shots have slowed to record lows, leaving millions of children unvaccinated.
Pfizer's CEO told "Face the Nation" on Sunday that he believed another booster shot was now "necessary."
Prevalence of this Omicron sub-lineage, sometimes misleadingly nicknamed a "stealth variant," now appears highest in the Northeast
"We are the compiler of the data, but we do not have the authority to collect it," CDC Director Dr. Rochelle Walensky told CBS News.
CEO Albert Bourla said the vaccine remains protective against hospitalizations and deaths, but "doesn't last very long" for warding off infections.